STRUCTURAL OUTCOMES IN THE SACROILIAC JOINT AFTER IXEKIZUMAB TREATMENT FOR 16 WEEKS IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY GENDER, HLA-B27, AND BASELINE MRI INFLAMMATION

被引：1

作者：

Maksymowych, W. P. ^{[1
]}

Baraliakos, X. ^{[2
]}

Lambert, R. G. ^{[3
]}

Landewe, R. B. M. ^{[4
]}

Sandoval, D. ^{[5
]}

Carlier, H. ^{[6
]}

Lisse, J. ^{[5
]}

Li, X. ^{[5
]}

Hojnik, M. ^{[5
]}

Ostergaard, M. ^{[7
,8
]}

机构：

[1] Univ Alberta, Div Rheumatol, Dept Med, Edmonton, AB, Canada

[2] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Herne, Germany

[3] Univ Alberta, Dept Radiol & Diagnost Imaging, Edmonton, AB, Canada

[4] Amsterdam Rheumatol & Immunol Ctr, Dept Clin Immunol & Rheumatol, Amsterdam, Netherlands

[5] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN USA

[6] Eli Lilly & Co, Immunol Med, Brussels, Belgium

[7] Rigshospitalet, Copenhagen Ctr Arthrit Res, Ctr Rheumatol & Spine Dis, Glostrup, Denmark

[8] Univ Copenhagen, Dept Clin Med, Glostrup, Denmark

来源：

关键词：

D O I：

10.1136/annrheumdis-2022-eular.2322

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0301

引用

页码：399 / 399

页数：1

共 32 条